The development of 3D-printed calcium phosphate bone grafts represents a breakthrough for personalized bone tissue engineering. However, their high brittleness is a limiting factor for clinical applications. The present work aims to overcome this drawback by developing a composite ink for direct ink writing using a polycaprolactone solution (20 wt% in pyridine) as binder for a self-hardening α-tricalcium phosphate powder. The ink consolidation results from a two-step process. First, evaporation of the solvent gives rise to a flexible green body, in which the polymer matrix retains the loose ceramic particles. Subsequently, upon contact with water, the hydrolysis of these particles creates a continuous network of biomimetic hydroxyapatite nanocrystals, with the consequent hardening of the ink. The presence of the polymer improves the mechanical properties, increasing the flexural strength from 2 to 4 MPa and the strain energy density from 0.2 to 1.1 kJ/m3. Unlike the inks based on hydrogel binders, where the hardening reaction starts as soon as the liquid and solid components are mixed, the ink prepared with the non-aqueous binder is stable, with over 5 months shelf life, and allows the hardening reaction to be triggered at will by contact with water.
No takes yet. Share an insight, caveat, or question.
del‐Mazo‐Barbara et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: